Literature DB >> 23979366

Recombinant soluble thrombomodulin as an adjunctive treatment for sepsis and disseminated intravascular coagulation: relatively safe and possibly effective.

Mitchell P Fink.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23979366     DOI： 10.1097/CCM.0b013e3182964037

Source DB:  PubMed          Journal:  Crit Care Med        ISSN： 0090-3493            Impact factor:   7.598


× No keyword cloud information.
  3 in total

1.  Induction of endothelium-dependent constriction of mesenteric arteries in endotoxemic hypotensive shock.

Authors:  Tzu-Ling Tseng; Mei-Fang Chen; Chin-Hung Liu; Cheng-Yoong Pang; Yung-Hsiang Hsu; Tony J F Lee
Journal:  Br J Pharmacol       Date:  2016-03-06       Impact factor: 8.739

2.  Targeting thrombomodulin to circulating red blood cells augments its protective effects in models of endotoxemia and ischemia-reperfusion injury.

Authors:  Ronald Carnemolla; Carlos H Villa; Colin F Greineder; Sergei Zaitsev; Kruti R Patel; M Anna Kowalska; Dmitriy N Atochin; Douglas B Cines; Don L Siegel; Charles T Esmon; Vladimir R Muzykantov
Journal:  FASEB J       Date:  2016-11-11       Impact factor: 5.191

3.  Use of recombinant human soluble thrombomodulin in patients with sepsis-induced disseminated intravascular coagulation after intestinal perforation.

Authors:  Takashi Tagami; Hiroki Matsui; Kiyohide Fushimi; Hideo Yasunaga
Journal:  Front Med (Lausanne)       Date:  2015-02-26
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.